Key facts
- This page summarizes Renee P. Tannenbaum's Form 4 filing for Cardiff Oncology, Inc. (CRDF).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Dec 2024, 17:00.
Renee P. Tannenbaum - 12 Dec 2024 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)
- Reporting relationship
- Director
- Issuer ticker
- CRDF
- Reported as of
- 12 Dec 2024
- Net transaction value
- +$34,224
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2024, 17:00:03 UTC
- Prior SEC filing
- 01 Jul 2024
- Next SEC filing
- 27 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Renee P Tannenbaum
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Renee P. Tannenbaum filed Form 4 for Cardiff Oncology, Inc. (CRDF) on 16 Dec 2024.
Change
- Previous filing in this sequence was filed on 01 Jul 2024.
- Current net transaction value: +$34,224.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRDF
transaction
Common Stock
Purchase
- Transaction value
- $34,224
- Shares
- +10,000
- Change %
- +100%
- Price
- $3.42
- Shares after
- 20,000
- Date
- 12 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.